{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:58:07Z","timestamp":1785448687872,"version":"3.56.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This review highlights differences in pathophysiologic mechanisms, diagnostic challenges and therapeutic responses of heart failure with preserved ejection fraction (HFpEF) in women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Emerging research provides further insight into the pathophysiology of HFpEF in women, and the role of obesity and its impact on treatment. Other theories highlight the role of microvascular dysfunction in women with HFpEF. Gender differences in cardiac imaging parameters for assessment of diastolic dysfunction and elevated filling pressures may require refinement for improved diagnostic accuracy of HFpEF in women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>HFpEF is fast becoming the dominant form of heart failure in the US and women have double the lifetime risk of developing HFpEF compared with heart failure with reduced ejection fraction. Gender-specific diagnostic parameters and treatment options have been hindered by low participation of women in cardiovascular trials. Increased participation in larger scale trials and further investigations into sex-specific pathophysiology are needed for improved outcomes in women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11886-026-02392-2","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:15:37Z","timestamp":1785399337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis to Outcomes"],"prefix":"10.1007","volume":"28","author":[{"given":"Sharon","family":"Andrade-Bucknor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Barforoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Elizabeth","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Lyubarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2392_CR1","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/J.JACC","volume":"86","author":"BA Borlaug","year":"2025","unstructured":"Borlaug BA. Do Heart Failure With Preserved Ejection Fraction Treatments Work by Targeting Adipose Biology? J Am Coll Cardiol. 2025;86:1236\u20139. https:\/\/doi.org\/10.1016\/J.JACC. 2025.07.046;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR2","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/J.CARDFAIL.2025.01.008","volume":"31","author":"A RADAKRISHNAN","year":"2025","unstructured":"Radakrishnan A, Agrawal S, Singh N, Barbieri Anna, Shaw LJ, GulatI M, et al. Underpinnings of Heart Failure With Preserved Ejection Fraction in Women - From Prevention to Improving Function. A Co-publication With the American Journal of Preventive Cardiology and the Journal of Cardiac Failure. J Card Fail. 2025;31:1460\u201375. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2025.01.008.","journal-title":"J Card Fail"},{"key":"2392_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijcard.2020.01.003","volume":"304","author":"CJ Pepine","year":"2020","unstructured":"Pepine CJ, Merz CNB, El Hajj S, Ferdinand KC, Hamilton MA, Lindley KJ, et al. Heart failure with preserved ejection fraction: similarities and differences between women and men. Int J Cardiol. 2020;304:101\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2020.01.003.","journal-title":"Int J Cardiol"},{"key":"2392_CR4","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/J.JACC","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017;70:2476\u201386. https:\/\/doi.org\/10.1016\/J.JACC. .2017.08.074;SUBPAGE:STRING:FULL.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/JAMA.2013.2024","volume":"309","author":"MM Redfield","year":"2013","unstructured":"Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309:1268\u201377. https:\/\/doi.org\/10.1001\/JAMA.2013.2024.","journal-title":"JAMA"},{"key":"2392_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1056\/NEJMOA1313731","volume":"370","author":"BP MA","year":"2014","unstructured":"MA BP, SF P, IS ARB. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370:10. https:\/\/doi.org\/10.1056\/NEJMOA1313731.","journal-title":"N Engl J Med"},{"key":"2392_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104795","author":"KP Kresoja","year":"2023","unstructured":"Kresoja KP, Unterhuber M, Wachter R, Rommel KP, Besler C, Shah S, et al. Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104795.","journal-title":"EBioMedicine"},{"key":"2392_CR8","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMOA1908655;WGROUP:STRING:MMS","volume":"381","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, et al. Angiotensin\u2013Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019;381:1609\u201320. https:\/\/doi.org\/10.1056\/NEJMOA1908655;WGROUP:STRING:MMS.","journal-title":"N Engl J Med"},{"key":"2392_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491;ISSUE:ISSUE:DOI","volume":"141","author":"JJV McMurray","year":"2020","unstructured":"McMurray JJV, Jackson AM, Lam CSP, Redfield MM, Anand IS, Ge J, et al. Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction Insights From PARAGON-HF. Circulation. 2020;141:338\u201351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.044491;ISSUE:ISSUE:DOI.","journal-title":"Circulation"},{"key":"2392_CR10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMOA2107038;SUBPAGE:STRING:FULL","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451\u201361. https:\/\/doi.org\/10.1056\/NEJMOA2107038;SUBPAGE:STRING:FULL.","journal-title":"N Engl J Med"},{"key":"2392_CR11","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/S41591-022-02041-5","volume":"28","author":"SD Anker","year":"2022","unstructured":"Anker SD, Butler J, Usman MS, Filippatos G, Ferreira JP, Bocchi E, et al. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved. Nat Med. 2022;28:2512\u201320. https:\/\/doi.org\/10.1038\/S41591-022-02041-5.","journal-title":"Nat Med"},{"key":"2392_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMOA2206286;PAGEGROUP:STRING:PUBLICATION","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022;387:1089\u201398. https:\/\/doi.org\/10.1056\/NEJMOA2206286;PAGEGROUP:STRING:PUBLICATION.","journal-title":"N Engl J Med"},{"key":"2392_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.122.062918;SUBPAGE:STRING:FULL","volume":"147","author":"T Kondo","year":"2023","unstructured":"Kondo T, Jering KS, Borleffs CJW, De Boer RA, Claggett BL, Desai AS, et al. Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 2023;147:1067\u201378. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062918;SUBPAGE:STRING:FULL.","journal-title":"Circulation"},{"key":"2392_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/JAMACARDIO.2023.0065","volume":"8","author":"M Ledwidge","year":"2023","unstructured":"Ledwidge M, Dodd JD, Ryan F, Sweeney C, McDonald K, Fox R, et al. Effect of sacubitril\/valsartan vs valsartan on left atrial volume in patients with pre\u2013heart failure with preserved ejection fraction: the PARABLE randomized clinical trial. JAMA Cardiol. 2023;8:366\u201375. https:\/\/doi.org\/10.1001\/JAMACARDIO.2023.0065.","journal-title":"JAMA Cardiol"},{"key":"2392_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1056\/NEJMOA2306963;WGROUP:STRING:MMS","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389:1069\u201384. https:\/\/doi.org\/10.1056\/NEJMOA2306963;WGROUP:STRING:MMS.","journal-title":"N Engl J Med"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jacc.2024.06.001","volume":"84","author":"S Verma","year":"2024","unstructured":"Verma S, Butler J, Borlaug BA, Davies M, Kitzman DW, Shah SJ, et al. Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials. J Am Coll Cardiol. 2024;84:773\u201385. https:\/\/doi.org\/10.1016\/j.jacc.2024.06.001.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR17","doi-asserted-by":"publisher","unstructured":"Borlaug B, Zile M, Kramer C et al. Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial. JACC. 2025 Jul, 86 (4) 242\u2013255. https:\/\/doi.org\/10.1016\/j.jacc.2025.04.059 Packer M. The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment. J Am Coll Cardiol 2025;86:1269\u2013373. https:\/\/doi.org\/10.1016\/J.JACC.2025.06.055;TAXONOMY:TAXONOMY:CME;PAGEGROUP:STRING:PUBLICATION.","DOI":"10.1016\/j.jacc.2025.04.059"},{"key":"2392_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jacc.2024.11.001","volume":"85","author":"CM Kramer","year":"2025","unstructured":"Kramer CM, Borlaug BA, Zile MR, Ruff D, DiMaria JM, Menon V, et al. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy. J Am Coll Cardiol. 2025;85:699\u2013706. https:\/\/doi.org\/10.1016\/j.jacc.2024.11.001.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMOA2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, et al. Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2024;391:1475\u201385. https:\/\/doi.org\/10.1056\/NEJMOA2407107.","journal-title":"N Engl J Med"},{"key":"2392_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/JAMACARDIO.2024.4613","volume":"10","author":"M Chimura","year":"2025","unstructured":"Chimura M, Wang X, Jhund PS, Henderson AD, Claggett BL, Desai AS, et al. Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial. JAMA Cardiol. 2025;10:59\u201370. https:\/\/doi.org\/10.1001\/JAMACARDIO.2024.4613.","journal-title":"JAMA Cardiol"},{"key":"2392_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","volume":"377","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(11)60101-3.","journal-title":"Lancet"},{"key":"2392_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","volume":"398","author":"JA Lindenfeld","year":"2021","unstructured":"Lindenfeld JA, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021;398:991\u20131001. https:\/\/doi.org\/10.1016\/S0140-6736(21)01754-2.","journal-title":"Lancet"},{"key":"2392_CR23","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/EJHF.3619","volume":"27","author":"A Bayes-Genis","year":"2025","unstructured":"Bayes-Genis A, Pagnesi M, Codina P, Abraham WT, Amir O, de Boer RA, et al. Remote pulmonary artery pressure-guided management of patients with heart failure: a clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025;27:1644. https:\/\/doi.org\/10.1002\/EJHF.3619.","journal-title":"Eur J Heart Fail"},{"key":"2392_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/JAMACARDIO.2024.0520","volume":"9","author":"RB Patel","year":"2024","unstructured":"Patel RB, Silvestry FE, Komtebedde J, Solomon SD, Hasenfu\u00df G, Litwin SE, et al. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. JAMA Cardiol. 2024;9:507\u201322. https:\/\/doi.org\/10.1001\/JAMACARDIO.2024.0520.","journal-title":"JAMA Cardiol"},{"key":"2392_CR25","unstructured":"Lam C, Kaye D, Hasenfu\u00df G, Cleland J, Cutlip D, Petrie M et al. Effects of Atrial Shunt Treatment in Women versus Men with HFpEF and HFmrEF: Results from the REDUCE LAP-HF II Trial n.d."},{"key":"2392_CR26","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jchf.2024.04.011","volume":"12","author":"F Gustafsson","year":"2024","unstructured":"Gustafsson F, Petrie MC, Komtebedde J, Swarup V, Winkler S, Hasenfu\u00df G, et al. 2-Year Outcomes of an Atrial Shunt Device in HFpEF\/HFmrEF: Results From REDUCE LAP-HF II. JACC Heart Fail. 2024;12:1425\u201338. https:\/\/doi.org\/10.1016\/j.jchf.2024.04.011.","journal-title":"JACC Heart Fail"},{"key":"2392_CR27","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","volume":"401","author":"JJ Brugts","year":"2023","unstructured":"Brugts JJ, Radhoe SP, Clephas PRD, Aydin D, van Gent MWF, Szymanski MK, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet. 2023;401:2113\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(23)00923-6.","journal-title":"Lancet"},{"key":"2392_CR28","doi-asserted-by":"publisher","unstructured":"Clephas PR, Zwartkruis VW, Malgie J, van Gent MW, Brunner-La Rocca H-P, Szymanski MK et al. Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial n.d. https:\/\/doi.org\/10.1093\/eurheartj\/ehae441","DOI":"10.1093\/eurheartj\/ehae441"},{"key":"2392_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.CARDFAIL.2024.07.001","volume":"31","author":"B Bozkurt","year":"2025","unstructured":"Bozkurt B, Ahmad T, Alexander K, Baker WL, Bosak K, Breathett K, et al. HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America. J Card Fail. 2025;31:66\u2013116. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2024.07.001.","journal-title":"J Card Fail"},{"key":"2392_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/EJHF.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition \u2026. Eur J Heart Fail. 2021;23:352\u201380. https:\/\/doi.org\/10.1002\/EJHF.2115.","journal-title":"Eur J Heart Fail"},{"key":"2392_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/21501319251367840","author":"K Yeh","year":"2025","unstructured":"Yeh K, Ansar M, Jamal H, Cannon J, Thampi S, Menon R, et al. A retrospective comparative study of sex-based risk variations in heart failure with preserved ejection fraction (HFpEF) versus heart failure with reduced ejection fraction (HFrEF). J Prim Care Community Health. 2025. https:\/\/doi.org\/10.1177\/21501319251367840.","journal-title":"J Prim Care Community Health"},{"key":"2392_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2024-093306","volume":"15","author":"L Li","year":"2025","unstructured":"Li L, Li Z, Xu P, Huang L, Peng X, Yue J, et al. Comorbidities and incidence of heart failure with preserved ejection fraction: a systematic review and meta-analysis of cohort studies. BMJ Open. 2025;15:e093306. https:\/\/doi.org\/10.1136\/BMJOPEN-2024-093306.","journal-title":"BMJ Open"},{"key":"2392_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117269","author":"A Rajendran","year":"2023","unstructured":"Rajendran A, Minhas AS, Kazzi B, Varma B, Choi E, Thakkar A, et al. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women. Atherosclerosis. 2023. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117269.","journal-title":"Atherosclerosis"},{"key":"2392_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/J.CARDFAIL.2021.10.006","volume":"28","author":"A Lala","year":"2022","unstructured":"Lala A, TAYAL U, HAMO CE, YOUMANS Q, AL-KHATIB SM, BOZKURT B, et al. Sex Differences in Heart Failure. J Card Fail. 2022;28:477\u201398. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2021.10.006.","journal-title":"J Card Fail"},{"key":"2392_CR35","doi-asserted-by":"publisher","unstructured":"Smereka Y, Ezekowitz JA. HFpEF and sex: understanding the role of sex differences. Https:\/\/DoiOrg\/101139\/Cjpp-2023-0403 2024;102:465\u201375. https:\/\/doi.org\/10.1139\/CJPP-2023-0403.","DOI":"10.1139\/CJPP-2023-0403"},{"key":"2392_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0033308","volume":"7","author":"NR Shah","year":"2012","unstructured":"Shah NR, Braverman ER. Measuring adiposity in patients: the utility of Body Mass Index (BMI), percent body fat, and leptin. PLoS One. 2012;7:e33308. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0033308.","journal-title":"PLoS One"},{"key":"2392_CR37","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/J.JACC.2025.06","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M. The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment. J Am Coll Cardiol. 2025;86:1269\u2013373. https:\/\/doi.org\/10.1016\/J.JACC.2025.06. .055;TAXONOMY:TAXONOMY:CME;PAGEGROUP:STRING:PUBLICATION.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR38","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/J.JACC","volume":"86","author":"S Verma","year":"2025","unstructured":"Verma S, Bhatt DL. Parsing the Adipokine Axis in HFpEF. J Am Coll Cardiol. 2025;86:1252\u20135. https:\/\/doi.org\/10.1016\/J.JACC. 2025.08.035;CTYPE:STRING:JOURNAL.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR39","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/J.JACC","volume":"86","author":"CSP Lam","year":"2025","unstructured":"Lam CSP, Kitzman DW. Obese HFpEF: From Pariah to Paradigm. J Am Coll Cardiol. 2025;86:1240\u20132. https:\/\/doi.org\/10.1016\/J.JACC. .2025.08.033;JOURNAL:JOURNAL:JAC;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"J Am Coll Cardiol"},{"key":"2392_CR40","doi-asserted-by":"publisher","unstructured":"Whitman J, Kozaily E, Michos ED, Silverman DN, Fudim M, Mentz RJ et al. Epicardial Fat in Heart Failure and Preserved Ejection Fraction: Novel Insights and Future Perspectives. Curr Heart Fail Rep 2025 22:1 2025;22:13-. https:\/\/doi.org\/10.1007\/S11897-025-00700-5","DOI":"10.1007\/S11897-025-00700-5"},{"key":"2392_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/J.HFC.2018.12.004","volume":"15","author":"M Obokata","year":"2019","unstructured":"Obokata M, Reddy YNV, Borlaug BA. The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction: What Do We Want from Imaging? Heart Fail Clin. 2019;15:241\u201356. https:\/\/doi.org\/10.1016\/J.HFC.2018.12.004.","journal-title":"Heart Fail Clin"},{"key":"2392_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/S10741-023-10362-X","volume":"29","author":"X Lin","year":"2023","unstructured":"Lin X, Wu G, Wang S, Huang J. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis. Heart Fail Reviews 2023. 2023;29:2. https:\/\/doi.org\/10.1007\/S10741-023-10362-X.","journal-title":"Heart Fail Reviews 2023"},{"key":"2392_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/S10741-024-10479-7","volume":"30","author":"O Velollari","year":"2025","unstructured":"Velollari O, Rommel KP, Kresoja KP, Lurz P, Gori T. Focusing on microvascular function in heart failure with preserved ejection fraction. Heart Fail Rev. 2025;30:493\u2013503. https:\/\/doi.org\/10.1007\/S10741-024-10479-7.","journal-title":"Heart Fail Rev"},{"key":"2392_CR44","doi-asserted-by":"publisher","first-page":"e70521","DOI":"10.14814\/PHY2.70521","volume":"13","author":"P Sen","year":"2025","unstructured":"Sen P, Wang L, d\u2019Ambrosio L, Bierschenk S, Hamers J, Ornek I, et al. Coronary microvascular disease in heart failure with preserved ejection fraction. Physiol Rep. 2025;13:e70521. https:\/\/doi.org\/10.14814\/PHY2.70521. ;CTYPE:STRING:JOURNAL.","journal-title":"Physiol Rep"},{"key":"2392_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/S10741-023-10369-4","volume":"29","author":"M Abubakar","year":"2024","unstructured":"Abubakar M, Saleem A, Hajjaj M, Faiz H, Pragya A, Jamil R, et al. Sex-specific differences in risk factors, comorbidities, diagnostic challenges, optimal management, and prognostic outcomes of heart failure with preserved ejection fraction: a comprehensive literature review. Heart Fail Rev. 2024;29:235\u201356. https:\/\/doi.org\/10.1007\/S10741-023-10369-4.","journal-title":"Heart Fail Rev"},{"key":"2392_CR46","doi-asserted-by":"publisher","first-page":"685996","DOI":"10.3389\/FCELL.2021.685996\/FULL","volume":"9","author":"AO Adekunle","year":"2021","unstructured":"Adekunle AO, Adzika GK, Mprah R, Ndzie Noah ML, Adu-Amankwaah J, Rizvi R, et al. Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency. Front Cell Dev Biol. 2021;9:685996. https:\/\/doi.org\/10.3389\/FCELL.2021.685996\/FULL.","journal-title":"Front Cell Dev Biol"},{"key":"2392_CR47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/S10741-025-10528-9","volume":"30","author":"IA Ebong","year":"2025","unstructured":"Ebong IA, Gill A, Appiah D, Mauricio R. Sex differences in the presentation, pathophysiology, and prognosis of heart failure with preserved ejection fraction. Heart Fail Rev. 2025;30:1045\u201359. https:\/\/doi.org\/10.1007\/S10741-025-10528-9.","journal-title":"Heart Fail Rev"},{"key":"2392_CR48","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/EHJCI\/JEW142","volume":"18","author":"C Gebhard","year":"2017","unstructured":"Gebhard C, Buechel RR, St\u00e4hli BE, Gransar H, Achenbach S, Berman DS, et al. Impact of age and sex on left ventricular function determined by coronary computed tomographic angiography: results from the prospective multicentre CONFIRM study. Eur Heart J Cardiovasc Imaging. 2017;18:990\u20131000. https:\/\/doi.org\/10.1093\/EHJCI\/JEW142.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2392_CR49","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1093\/EURHEARTJ\/EHZ641","volume":"40","author":"B Pieske","year":"2019","unstructured":"Pieske B, Tsch\u00f6pe C, De Boer RA, Fraser AG, Anker SD, Donal E, et al. How to diagnose heart failure with preserved ejection fraction: the HFA\u2013PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40:3297\u2013317. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHZ641.","journal-title":"Eur Heart J"},{"key":"2392_CR50","doi-asserted-by":"publisher","unstructured":"Cediel G, Codina P, Spitaleri G, Domingo M, Santiago-Vacas E, Lup\u00f3n J et al. Gender-Related Differences in Heart Failure Biomarkers. Front Cardiovasc Med 2021;7. https:\/\/doi.org\/10.3389\/FCVM.2020.617705","DOI":"10.3389\/FCVM.2020.617705"},{"key":"2392_CR51","doi-asserted-by":"publisher","first-page":"A29","DOI":"10.1136\/HEARTJNL-2023-ICS.26","volume":"109","author":"B Wong","year":"2023","unstructured":"Wong B, Gallagher J, Dodd J, Murphy D, McDonald K, Ledwidge M. 26 Sex-related cardiovascular differences in pre-HFpEF; a report from the PARABLE trial. Heart. 2023;109:A29\u201330. https:\/\/doi.org\/10.1136\/HEARTJNL-2023-ICS.26.","journal-title":"Heart"},{"key":"2392_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/S10741-020-09913-3","volume":"26","author":"SW Rabkin","year":"2020","unstructured":"Rabkin SW, Tang JKK. The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review. Heart Fail Reviews 2020. 2020;26:4. https:\/\/doi.org\/10.1007\/S10741-020-09913-3.","journal-title":"Heart Fail Reviews 2020"},{"key":"2392_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13164627","volume":"13","author":"AM Vrabie","year":"2024","unstructured":"Vrabie AM, Totolici S, Delcea C, Badila E. Biomarkers in heart failure with preserved ejection fraction: a perpetually evolving frontier. J Clin Med. 2024;13:4627. https:\/\/doi.org\/10.3390\/JCM13164627.","journal-title":"J Clin Med"},{"key":"2392_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-025-23059-Y","volume":"15","author":"J Mazur","year":"2025","unstructured":"Mazur J, Gil KE, Mikrut K, Black AL, Smart S, Truong VT, et al. Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts. Sci Rep. 2025;15:39331. https:\/\/doi.org\/10.1038\/S41598-025-23059-Y.","journal-title":"Sci Rep"},{"key":"2392_CR55","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.echo.2025.03.011","volume":"38","author":"SF Nagueh","year":"2025","unstructured":"Nagueh SF, Sanborn DY, Oh JK, Anderson B, Billick K, Derumeaux G, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38:537\u201369. https:\/\/doi.org\/10.1016\/j.echo.2025.03.011.","journal-title":"J Am Soc Echocardiogr"},{"key":"2392_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-7120-7-42","volume":"7","author":"C Ginghina","year":"2009","unstructured":"Ginghina C, Beladan CC, Iancu M, Calin A, Popescu BA. Respiratory maneuvers in echocardiography: a review of clinical applications. Cardiovasc Ultrasound. 2009;7:42. https:\/\/doi.org\/10.1186\/1476-7120-7-42.","journal-title":"Cardiovasc Ultrasound"},{"key":"2392_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/S10741-023-10360-Z","volume":"29","author":"F Formiga","year":"2024","unstructured":"Formiga F, Nu\u00f1ez J, Castillo Moraga MJ, Cobo Marcos M, Egocheaga MI, Garc\u00eda-Prieto CF, et al. Diagnosis of heart failure with preserved ejection fraction: a systematic narrative review of the evidence. Heart Fail Rev. 2024;29:179\u201389. https:\/\/doi.org\/10.1007\/S10741-023-10360-Z.","journal-title":"Heart Fail Rev"},{"key":"2392_CR58","doi-asserted-by":"publisher","unstructured":"van Ommen AMLN, Canto ED, Cramer MJ, Rutten FH, Onland-Moret NC, Ruijter HM. den. Diastolic dysfunction and sex-specific progression to HFpEF: current gaps in knowledge and future directions. BMC Medicine 2022 20:1 2022;20:496-. https:\/\/doi.org\/10.1186\/S12916-022-02650-4","DOI":"10.1186\/S12916-022-02650-4"},{"key":"2392_CR59","doi-asserted-by":"publisher","unstructured":"Cirener LC, K\u00f6rperich H, Barth P, Racolta A, Piran M, Burchert W et al. Assessing diastolic function using CMR as an alternative to echocardiography: age- and gender-related normal reference values. Clin Res Cardiol 2024 2024:1\u201317. https:\/\/doi.org\/10.1007\/S00392-024-02553-9","DOI":"10.1007\/S00392-024-02553-9"},{"key":"2392_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/S11886-025-02250-7","author":"J Chung","year":"2025","unstructured":"Chung J, Thangathurai J, Andrade-Bucknor S, Parashar S, Carta KG, Epp M, et al. The impact of artificial intelligence on women\u2019s cardiovascular disease care. Curr Cardiol Rep. 2025. https:\/\/doi.org\/10.1007\/S11886-025-02250-7.","journal-title":"Curr Cardiol Rep"},{"key":"2392_CR61","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/EHJCI\/JEAA164","volume":"21","author":"RJH Miller","year":"2020","unstructured":"Miller RJH, Mikami Y, Heydari B, Wilton SB, James MT, Howarth AG, et al. Sex-specific relationships between patterns of ventricular remodelling and clinical outcomes. Eur Heart J Cardiovasc Imaging. 2020;21:983\u201390. https:\/\/doi.org\/10.1093\/EHJCI\/JEAA164.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2392_CR62","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale AL, Meyer PMD, Marwick TH, Lam CSP, Kaye DM. Sex differences in cardiovascular pathophysiology why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138:198\u2013205. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034271. ;WEBSITE:WEBSITE:AHA-SITE;ISSUE:ISSUE:DOI.","journal-title":"Circulation"},{"key":"2392_CR63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/J.JCMG.2022.02","volume":"15","author":"EF Davis","year":"2022","unstructured":"Davis EF, Crousillat DR, He W, Andrews CT, Hung JW, Danik JS. Indexing Left Atrial Volumes: Alternative Indexing Methods Better Predict Outcomes in Overweight and Obese Populations. JACC Cardiovasc Imaging. 2022;15:989\u201397. https:\/\/doi.org\/10.1016\/J.JCMG.2022.02. .006;JOURNAL:JOURNAL:JCMG;REQUESTEDJOURNAL:JOURNAL:JCMG;PAGEGROUP:STRING:PUBLICATION.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2392_CR64","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.echo.2022.05.014","volume":"35","author":"FJ Olsen","year":"2022","unstructured":"Olsen FJ, Biering-S\u00f8rensen T. Validation of alternative left atrial indexation methods in obesity. J Am Soc Echocardiogr. 2022;35:1184\u20135. https:\/\/doi.org\/10.1016\/j.echo.2022.05.014.","journal-title":"J Am Soc Echocardiogr"},{"key":"2392_CR65","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/ECHO.13323","volume":"33","author":"ME Menting","year":"2016","unstructured":"Menting ME, McGhie JS, Koopman LP, Vletter WB, Helbing WA, van den Bosch AE, et al. Normal myocardial strain values using 2D speckle tracking echocardiography in healthy adults aged 20 to 72 years. Echocardiography. 2016;33:1665\u201375. https:\/\/doi.org\/10.1111\/ECHO.13323.","journal-title":"Echocardiography"},{"key":"2392_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/OPENHRT-2019-001050","author":"A St\u00f8ylen","year":"2019","unstructured":"St\u00f8ylen A, M\u00f8lmen HE, Dalen H. Left ventricular global strains by linear measurements in three dimensions: interrelations and relations to age, gender and body size in the HUNT study. Open Heart. 2019. https:\/\/doi.org\/10.1136\/OPENHRT-2019-001050.","journal-title":"Open Heart"},{"key":"2392_CR67","doi-asserted-by":"publisher","unstructured":"Shinzato MH, Santos N, Nishida G, Moriya H, Assef J, Feres F et al. Left ventricular and atrial myocardial strain in heart failure with preserved ejection fraction: the evidence so far and prospects for phenotyping strategy. Cardiovasc Ultrasound 2024 22:1 2024;22:4\u2013. https:\/\/doi.org\/10.1186\/S12947-024-00323-1","DOI":"10.1186\/S12947-024-00323-1"},{"key":"2392_CR68","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jcmg.2019.07.020","volume":"13","author":"N D\u2019Elia","year":"2020","unstructured":"D\u2019Elia N, Caselli S, Kosmala W, Lancellotti P, Morris D, Muraru D, et al. Normal Global Longitudinal Strain: An Individual Patient Meta-Analysis. JACC Cardiovasc Imaging. 2020;13:167\u20139. https:\/\/doi.org\/10.1016\/j.jcmg.2019.07.020.","journal-title":"JACC Cardiovasc Imaging"},{"key":"2392_CR69","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/EHJCI\/JEAB032","volume":"23","author":"KG Skaarup","year":"2022","unstructured":"Skaarup KG, Lassen MCH, Johansen ND, Olsen FJ, Lind JN, J\u00f8rgensen PG, et al. Age- and sex-based normal values of layer-specific longitudinal and circumferential strain by speckle tracking echocardiography: the Copenhagen City Heart Study. Eur Heart J Cardiovasc Imaging. 2022;23:629\u201340. https:\/\/doi.org\/10.1093\/EHJCI\/JEAB032.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2392_CR70","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/EJHF.754","volume":"19","author":"AD DeVore","year":"2017","unstructured":"DeVore AD, McNulty S, Alenezi F, Ersboll M, Vader JM, Oh JK, et al. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. Eur J Heart Fail. 2017;19:893\u2013900. https:\/\/doi.org\/10.1002\/EJHF.754.","journal-title":"Eur J Heart Fail"},{"key":"2392_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/EHJCI\/JEAE333.467","author":"G Kim","year":"2025","unstructured":"Kim G, Kim K, Gwak S, Lee H, Cho I, Hong G, et al. Heart failure with preserved global longitudinal strain: a distinct phenotype in patients with preserved ejection fraction: data from a real-world registry. Eur Heart J Cardiovasc Imaging. 2025. https:\/\/doi.org\/10.1093\/EHJCI\/JEAE333.467.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2392_CR72","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/ECHO.13094","volume":"33","author":"M Cameli","year":"2016","unstructured":"Cameli M, Sparla S, Losito M, Righini FM, Menci D, Lisi M, et al. Correlation of left atrial strain and doppler measurements with invasive measurement of left ventricular end-diastolic pressure in patients stratified for different values of ejection fraction. Echocardiography. 2016;33:398\u2013405. https:\/\/doi.org\/10.1111\/ECHO.13094.","journal-title":"Echocardiography"},{"key":"2392_CR73","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/LIFE15020313","volume":"15","author":"DE Man","year":"2025","unstructured":"Man DE, Motofelea AC, Buda V, Velimirovici DE, Bodea O, Duda-Seiman DM, et al. Left Atrial Strain in Patients with Chronic Heart Failure with Preserved Ejection Fraction: A Narrative Review. Life 2025. Page 313. 2025;15:15:313. https:\/\/doi.org\/10.3390\/LIFE15020313.","journal-title":"Page 313"},{"key":"2392_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/JPM14111093","volume":"14","author":"N Javadi","year":"2024","unstructured":"Javadi N, Bismee NN, Abbas MT, Scalia IG, Pereyra M, Baba Ali N, et al. Left atrial strain: state of the art and clinical implications. J Pers Med. 2024;14:1093. https:\/\/doi.org\/10.3390\/JPM14111093.","journal-title":"J Pers Med"},{"key":"2392_CR75","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/EJHF.1643;WGROUP:STRING:PUBLICATION","volume":"22","author":"MS Khan","year":"2020","unstructured":"Khan MS, Memon MM, Murad MH, Vaduganathan M, Greene SJ, Hall M, et al. Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2020;22:472\u201385. https:\/\/doi.org\/10.1002\/EJHF.1643;WGROUP:STRING:PUBLICATION.","journal-title":"Eur J Heart Fail"},{"key":"2392_CR76","doi-asserted-by":"publisher","unstructured":"Coppi F, Pagnoni G, Grossule F, Nassar A, Maini A, Masaracchia G, et al. Gender-Specific Differences in Diastolic Dysfunction and HFpEF: Pathophysiology, Diagnosis, and Therapeutic Strategies. J Cardiovasc Dev Disease 2025. Page 213 2025;12:12:213. https:\/\/doi.org\/10.3390\/JCDD12060213.","DOI":"10.3390\/JCDD12060213"},{"key":"2392_CR77","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/S11886-024-02058-X\/FIGURES\/2","volume":"26","author":"A Serafin","year":"2024","unstructured":"Serafin A, Kosmala W, Marwick TH. Evolving Applications of Echocardiography in the Evaluation of Left Atrial and Right Ventricular Strain. Curr Cardiol Rep. 2024;26:593\u2013600. https:\/\/doi.org\/10.1007\/S11886-024-02058-X\/FIGURES\/2.","journal-title":"Curr Cardiol Rep"},{"key":"2392_CR78","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/EHJCI\/JEAD196","volume":"24","author":"OA Smiseth","year":"2023","unstructured":"Smiseth OA, Donal E, Boe E, Ha JW, Fernandes JF, Lamata P. Phenotyping heart failure by echocardiography: imaging of ventricular function and haemodynamics at rest and exercise. Eur Heart J Cardiovasc Imaging. 2023;24:1329\u201342. https:\/\/doi.org\/10.1093\/EHJCI\/JEAD196.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2392_CR79","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.echo.2014.06.007","volume":"27","author":"EM Chia","year":"2014","unstructured":"Chia EM, Hsieh CHC, Boyd A, Pham P, Vidaic J, Leung D, et al. Effects of age and gender on right ventricular systolic and diastolic function using two-dimensional speckle-tracking strain. J Am Soc Echocardiogr. 2014;27:1079\u2013e10861. https:\/\/doi.org\/10.1016\/j.echo.2014.06.007.","journal-title":"J Am Soc Echocardiogr"},{"key":"2392_CR80","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.hfc.2023.06.001","volume":"19","author":"E Sciatti","year":"2023","unstructured":"Sciatti E, Coccia MG, Magnano R, Aakash G, Limonta R, Diep B, et al. Heart Failure Preserved Ejection Fraction in Women: Insights Learned from Imaging. Heart Fail Clin. 2023;19:461\u201373. https:\/\/doi.org\/10.1016\/j.hfc.2023.06.001.","journal-title":"Heart Fail Clin"},{"key":"2392_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2025.06.012","author":"A Popat","year":"2025","unstructured":"Popat A, Yadav S, Pethe G, Rehman A, Sharma P, Rezkalla S. The role of POCUS in diagnosing acute heart failure in the emergency department: A meta-analysis. J Cardiol. 2025. https:\/\/doi.org\/10.1016\/j.jjcc.2025.06.012.","journal-title":"J Cardiol"},{"key":"2392_CR82","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646;WGROUP:STRING:PUBLICATION","volume":"138","author":"YNV Reddy","year":"2018","unstructured":"Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138:861\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034646;WGROUP:STRING:PUBLICATION.","journal-title":"Circulation"},{"key":"2392_CR83","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/J.JJCC.2021.11.003","volume":"79","author":"T Harada","year":"2022","unstructured":"Harada T, Kagami K, Kato T, Obokata M. Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction. J Cardiol. 2022;79:679\u201390. https:\/\/doi.org\/10.1016\/J.JJCC.2021.11.003.","journal-title":"J Cardiol"},{"key":"2392_CR84","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/J.JCHF.2020.03","volume":"8","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW, et al. Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail. 2020;8:640\u201353. https:\/\/doi.org\/10.1016\/J.JCHF.2020.03. .013;WEBSITE:WEBSITE:ACCPUBS;ISSUE:ISSUE:DOI.","journal-title":"JACC Heart Fail"},{"key":"2392_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100452","author":"AP Akerman","year":"2023","unstructured":"Akerman AP, Porumb M, Scott CG, Beqiri A, Chartsias A, Ryu AJ, et al. Automated echocardiographic detection of heart failure with preserved ejection fraction using artificial intelligence. JACC Adv. 2023. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100452.","journal-title":"JACC Adv"},{"key":"2392_CR86","doi-asserted-by":"publisher","DOI":"10.1093\/EURHEARTJ\/EHAE666.1216","author":"V Subramanian","year":"2024","unstructured":"Subramanian V, Chandra A, Segar M, Yaros K, Upton R, Akerman A, et al. Performance of an automated echocardiographic artificial intelligence model. To detect subclinical heart failure with preserved ejection fraction (HFpEF) in community-dwelling older adults. Eur Heart J. 2024. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAE666.1216.","journal-title":"Eur Heart J"},{"key":"2392_CR87","doi-asserted-by":"publisher","unstructured":"Akerman AP, Al-Roub N, Angell-James C, Cassidy MA, Thompson R, Bosque L et al. External validation of artificial intelligence for detection of heart failure with preserved ejection fraction. Nat Commun 2025 16:1 2025;16:2915-. https:\/\/doi.org\/10.1038\/s41467-025-58283-7","DOI":"10.1038\/s41467-025-58283-7"},{"key":"2392_CR88","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/J.JACC.2023.01","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. J Am Coll Cardiol. 2023;81:1810\u201334. https:\/\/doi.org\/10.1016\/J.JACC.2023.01. .049;WEBSITE:WEBSITE:ACCPUBS;PAGEGROUP:STRING:PUBLICATION.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2392_CR89","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063.","journal-title":"Circulation"},{"key":"2392_CR90","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.amjcard.2017.02.045","volume":"119","author":"WT O\u2019Neal","year":"2017","unstructured":"O\u2019Neal WT, Sandesara P, Hammadah M, Venkatesh S, Samman-Tahhan A, Kelli HM, et al. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2017;119:1785\u201390. https:\/\/doi.org\/10.1016\/j.amjcard.2017.02.045.","journal-title":"Am J Cardiol"},{"key":"2392_CR91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.amjcard.2017.04.043","volume":"120","author":"K Kajimoto","year":"2017","unstructured":"Kajimoto K, Minami Y, Sato N, Otsubo S, Kasanuki H. Gender differences in anemia and survival in patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction. Am J Cardiol. 2017;120:435\u201342. https:\/\/doi.org\/10.1016\/j.amjcard.2017.04.043.","journal-title":"Am J Cardiol"},{"key":"2392_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijcard.2019.08.049.PMID:31521440","volume":"298","author":"G Savarese","year":"2020","unstructured":"Savarese G, Jonsson \u00c5, Hallberg AC, Dahlstr\u00f6m U, Edner M, Lund LH. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum. Int J Cardiol. 2020;298:59\u201365. https:\/\/doi.org\/10.1016\/j.ijcard.2019.08.049.PMID:31521440.","journal-title":"Int J Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02392-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02392-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:03:46Z","timestamp":1785445426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02392-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02392-2","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}